Literature DB >> 26996433

Burden of community-onset bloodstream infections, Western Interior, British Columbia, Canada.

K B Laupland1, K Pasquill2, E C Parfitt1, P Naidu3, L Steele2.   

Abstract

Although community-onset bloodstream infection (BSI) is recognized as a major cause of morbidity and mortality, its epidemiology has not been well defined in non-selected populations. We conducted population-based surveillance in the Interior Health West region of British Columbia, Canada in order to determine the burden associated with community-onset BSI. A total of 1088 episodes were identified for an overall annual incidence of 117·8/100 000 of which 639 (58·7%) were healthcare-associated (HA) and 449 (41·3%) were community-associated (CA) BSIs for incidences of 69·2 and 48·6/100 000, respectively. The incidence of community-onset BSI varied by age and gender and elderly males were at the highest risk. Overall 964 (88·6%) episodes resulted in hospital admission for a median length of stay of 8 days; the total days of acute hospitalization associated with community-onset BSI was 13 530 days or 1465 days/100 000 population per year. The in-hospital mortality rate was 10·6% (102/964) and this was higher for HA-BSI (72/569, 12·7%) compared to CA-BSI (30/395, 7·6%, P = 0·014) episodes. Community-onset BSI, especially HA-BSI, is associated with a major burden of illness.

Entities:  

Keywords:  Bacterial infections; bloodstream infections; epidemiology

Mesh:

Year:  2016        PMID: 26996433      PMCID: PMC9150510          DOI: 10.1017/S0950268816000613

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  31 in total

1.  Bloodstream infections in adults: importance of healthcare-associated infections.

Authors:  J Vallés; E Calbo; E Anoro; D Fontanals; M Xercavins; E Espejo; G Serrate; N Freixas; M A Morera; B Font; F Bella; F Segura; J Garau
Journal:  J Infect       Date:  2007-11-19       Impact factor: 6.072

2.  Antimicrobial resistance surveillance systems: Are potential biases taken into account?

Authors:  Olivia Rempel; Johann Dd Pitout; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

3.  Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study.

Authors:  Marin H Kollef; Marya D Zilberberg; Andrew F Shorr; Lien Vo; Jeffrey Schein; Scott T Micek; Myoung Kim
Journal:  J Infect       Date:  2010-12-30       Impact factor: 6.072

4.  Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England.

Authors:  J K Abernethy; A P Johnson; R Guy; N Hinton; E A Sheridan; R J Hope
Journal:  Clin Microbiol Infect       Date:  2015-01-14       Impact factor: 8.067

5.  Burden of community-onset bloodstream infection: a population-based assessment.

Authors:  K B Laupland; D B Gregson; W W Flemons; D Hawkins; T Ross; D L Church
Journal:  Epidemiol Infect       Date:  2006-12-07       Impact factor: 2.451

6.  Bacteremia in Charleston County, South Carolina.

Authors:  G A Filice; L L Van Etta; C P Darby; D W Fraser
Journal:  Am J Epidemiol       Date:  1986-01       Impact factor: 4.897

7.  Defining the epidemiology of bloodstream infections: the 'gold standard' of population-based assessment.

Authors:  K B Laupland
Journal:  Epidemiol Infect       Date:  2012-12-06       Impact factor: 4.434

8.  Epidemiology of community-onset bloodstream infections in Bouaké, central Côte d'Ivoire.

Authors:  C Akoua-Koffi; H Tia; J K Plo; P Monemo; A Cissé; C Yao; P J Yenan; F S Touré; V Ilupeju; I I Bogoch; J Utzinger; M Herrmann; S L Becker
Journal:  New Microbes New Infect       Date:  2015-07-16

9.  Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study.

Authors:  Deverick J Anderson; Rebekah W Moehring; Richard Sloane; Kenneth E Schmader; David J Weber; Vance G Fowler; Emily Smathers; Daniel J Sexton
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

10.  Community-onset bloodstream infection with multidrug-resistant organisms: a matched case-control study.

Authors:  Ching Jou Lim; Allen C Cheng; David C M Kong; Anton Y Peleg
Journal:  BMC Infect Dis       Date:  2014-03-04       Impact factor: 3.090

View more
  6 in total

1.  Population-based risk factors for community-onset bloodstream infections.

Authors:  Kevin B Laupland; Kelsey Pasquill; Gabrielle Dagasso; Elizabeth C Parfitt; Lisa Steele; Henrik C Schonheyder
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-19       Impact factor: 3.267

2.  Burden of bloodstream infection in an area of Mid-Norway 2002-2013: a prospective population-based observational study.

Authors:  Arne Mehl; Bjørn Olav Åsvold; Stian Lydersen; Julie Paulsen; Erik Solligård; Jan Kristian Damås; Stig Harthug; Tom-Harald Edna
Journal:  BMC Infect Dis       Date:  2017-03-11       Impact factor: 3.090

3.  Inhospital death is a biased measure of fatal outcome from bloodstream infection.

Authors:  Kevin B Laupland; Kelsey Pasquill; Elizabeth C Parfitt; Gabrielle Dagasso; Kaveri Gupta; Lisa Steele
Journal:  Clin Epidemiol       Date:  2019-01-04       Impact factor: 4.790

4.  Occurrence and determinants of Klebsiella species bloodstream infection in the western interior of British Columbia, Canada.

Authors:  Connor B Reid; Lisa Steele; Kelsey Pasquill; Elizabeth C Parfitt; Kevin B Laupland
Journal:  BMC Infect Dis       Date:  2019-12-19       Impact factor: 3.090

5.  Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort study.

Authors:  Melissa C MacKinnon; Scott A McEwen; David L Pearl; Outi Lyytikäinen; Gunnar Jacobsson; Peter Collignon; Daniel B Gregson; Louis Valiquette; Kevin B Laupland
Journal:  Antimicrob Resist Infect Control       Date:  2021-09-06       Impact factor: 4.887

6.  Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study.

Authors:  Melissa C MacKinnon; Scott A McEwen; David L Pearl; Outi Lyytikäinen; Gunnar Jacobsson; Peter Collignon; Daniel B Gregson; Louis Valiquette; Kevin B Laupland
Journal:  BMC Infect Dis       Date:  2021-06-25       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.